Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul John Devlin Insider Profile
4 Followers
Paul John Devlin, Finance Director at Tissue Regenix, holds 300.00K shares in Tissue Regenix (Ticker: GB:TRX). Most recently, Paul John Devlin Bought 300,000p shares of Tissue Regenix on Aug 09, 2017 for an estimated value of 30.00K.
Paul John Devlin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Paul John Devlin's holdings
Insider Roles
Finance Director
Roles that Paul John Devlin holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Paul John Devlin
Paul John Devlin's Trading History
List of latest transactions for each holding click on a transaction to see Paul John Devlin's performance on stock
You May Also Like
Paul John Devlin insider profile FAQ
What is the percentage of profitable transactions made by Paul John Devlin?
The percentage of profitable transactions made by Paul John Devlin is ―.
What is the average return per transaction made by Paul John Devlin?
The average return per transaction made by Paul John Devlin is ―.
What stocks does Paul John Devlin hold?
Paul John Devlin holds: GB:TRX stocks.
What was Paul John Devlin’s latest transaction?
Paul John Devlin latest transaction was an Informative Buy of 30.00K.
What was Paul John Devlin's most profitable transaction?
Paul John Devlin’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Paul John Devlin's role in Tissue Regenix?
Paul John Devlin's role in Tissue Regenix is Finance Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.